Loading...
Nanosonics Limited
NNCSF•PNK
Healthcare
Medical - Instruments & Supplies
$2.45
$-0.20(-7.55%)
Nanosonics Limited (NNCSF) Financial Performance & Income Statement Overview
View comprehensive annual and quarterly summaries for Nanosonics Limited (NNCSF), featuring income statements, balance sheets, and cash flow data.
Revenue Growth
2.42%
↑ 2.42%
Operating Income Growth
-49.35%
↓ 49.35%
Net Income Growth
-34.76%
↓ 34.76%
Operating Cash Flow Growth
-2.28%
↓ 2.28%
Operating Margin
5.36%
↑ 5.36%
Gross Margin
77.90%
↑ 77.90%
Net Profit Margin
7.63%
↑ 7.63%
ROE
7.25%
↑ 7.25%
ROIC
4.44%
↑ 4.44%
Nanosonics Limited (NNCSF) Income Statement & Financial Overview
Review Nanosonics Limited NNCSF income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|
| Revenue | $90.37M | $80.65M | $85.72M | $42.21M |
| Cost of Revenue | $21.38M | $16.19M | $18.15M | $9.07M |
| Gross Profit | $68.99M | $64.46M | $67.57M | $33.14M |
| Gross Profit Ratio | $0.76 | $0.80 | $0.79 | $0.79 |
| R&D Expenses | $16.60M | $16.21M | $15.88M | $7.94M |
| SG&A Expenses | $48.17M | $44.62M | $43.77M | $21.88M |
| Operating Expenses | $62.90M | $60.83M | $59.65M | $28.65M |
| Total Costs & Expenses | $84.28M | $77.02M | $77.79M | $37.72M |
| Interest Income | $2.66M | $2.31M | $1.72M | $615500.00 |
| Interest Expense | $626000.00 | $479000.00 | $485000.00 | $0.00 |
| Depreciation & Amortization | $3.85M | $3.78M | $3.52M | $1.006M |
| EBITDA | $12.60M | $9.12M | $11.45M | $4.66M |
| EBITDA Ratio | $0.14 | $0.09 | $0.13 | $0.11 |
| Operating Income | $6.09M | $3.63M | $7.93M | $3.65M |
| Operating Income Ratio | $0.07 | $0.04 | $0.09 | $0.09 |
| Other Income/Expenses (Net) | $2.03M | $1.23M | -$2.82M | $615500.00 |
| Income Before Tax | $8.12M | $4.86M | $10.22M | $5.11M |
| Income Before Tax Ratio | $0.09 | $0.06 | $0.12 | $0.12 |
| Income Tax Expense | $1.32M | -$1.31M | $706000.00 | $353000.00 |
| Net Income | $6.80M | $6.17M | $9.51M | $4.76M |
| Net Income Ratio | $0.08 | $0.08 | $0.11 | $0.11 |
| EPS | $0.02 | $0.02 | $0.03 | $0.02 |
| Diluted EPS | $0.02 | $0.02 | $0.03 | $0.02 |
| Weighted Avg Shares Outstanding | $303.00M | $301.69M | $302.32M | $307.80M |
| Weighted Avg Shares Outstanding (Diluted) | $312.18M | $305.58M | $307.45M | $307.34M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan